CureVac Corporate Services GmbH

CureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac AG, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing the versatile biological molecule for medical purposes. Our focus is on prophylactic vaccines, innovative cancer immunotherapies, and protein-based therapies. All RNA people are striving to achieve our main joint goal: To bring multiple best-in-class mRNA medicines to market.